Ramon and Cajal University Hospital, Madrid (Spain)
0
follower
4
more
presentations
in this session
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry